Forward Look

As patents expire on biologic drugs, cancer patients get new options.

by Stephen Ornes

Forward Look

Targeted therapy approvals increase options and hope for some patients.

by Cameron Walker

Q&A

In her first book, journalist and breast cancer survivor Kate Pickert traces the winding road of cancer research and patient advocacy.

by Marci A. Landsmann

Forward Look

Experts say it's necessary to look behind the statistics.

by Delia O’Hara

Policy Matters

The AACR and the FDA presented joint recommendations that include broadening clinical trial eligibility and engaging the community in clinical trial recruitment.

by Kenneth C. Anderson, MD; Lola A. Fashoyin-Aje, MD, MPH; Nicole Gormley, MD; and Paul G. Kluetz, MD

Using robotic assistants for cancer surgery has become commonplace. Whether cancer patients benefit when a surgeon uses a robot remains unclear.

by Sue Rochman

Survivor Profile

Diagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer.

by Lindsey Konkel

My diagnosis with colorectal cancer at age 32 affected my fertility. As a result of my experiences, I help others who have been diagnosed with cancer understand their choices related to fertility preservation and their options for becoming a parent.

by Allison Rosen

Some cancers that are most commonly diagnosed in older adults are becoming increasingly prevalent in young adults.

by Kate Yandell

Research describes how communication gaps can shift extra burden to parents who are members of ethnic and racial minority groups.

by Marci A. Landsmann